Strides Pharma Science Ltd (SRID)

BSE
Currency in INR
578.65
-32.00(-5.24%)
Delayed Data
SRID Scorecard
Full Analysis
High shareholder yield
Earnings results expected in 14 days
Fair Value
Day's Range
575.85613.60
52 wk Range
294.81880.55
Key Statistics
Edit
Bid/Ask
578.70 / 579.20
Prev. Close
610.65
Open
610.6
Day's Range
575.85-613.6
52 wk Range
294.81-880.55
Volume
30.44K
Average Volume (3m)
47.05K
1-Year Change
-10.01%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SRID Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year
Show more

Strides Pharma Science Ltd Company Profile

Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, gels, powders, solids, ointments, and creams. It also develops branded generics products for the treatment of chronic therapies, including women’s health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.

Employees
3065
Market
India

Compare SRID to Peers and Sector

Metrics to compare
SRID
Peers
Sector
Relationship
P/E Ratio
31.8x15.2x−0.6x
PEG Ratio
0.160.070.00
Price/Book
2.5x2.4x2.6x
Price / LTM Sales
1.3x1.5x3.1x
Upside (Analyst Target)
91.9%9.0%54.6%
Fair Value Upside
Unlock−13.9%7.7%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 25.19
Dividend Yield
0.41%
Industry Median 0.70%
Annualised payout
2.5000
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Oct 24, 2024
EPS / Forecast
4.80 / --
Revenue / Forecast
12.01B / 11.12B
EPS Revisions
Last 90 days

FAQ

What Is the Strides Pharma (SRID) Stock Price Today?

The Strides Pharma stock price today is 578.65.

What Stock Exchange Does Strides Pharma Trade On?

Strides Pharma is listed and trades on the BSE stock exchange.

What Is the Stock Symbol for Strides Pharma?

The stock symbol for Strides Pharma is "SRID."

Does Strides Pharma Pay Dividends? What’s The Current Dividend Yield?

The Strides Pharma Science Ltd dividend yield is 0.41%.

What Is the Strides Pharma Market Cap?

As of today, Strides Pharma market cap is 53.14B.

What is Strides Pharma Earnings Per Share?

The Strides Pharma EPS is 25.19.

What Is the Next Strides Pharma Earnings Date?

Strides Pharma will release its next earnings report on 03 Feb 2025.

From a Technical Analysis Perspective, Is SRID a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.